My Home >News & Events > Press Releases Thursday, August 28, 2008  

Login ID

Password

Remember my Login
Forgot Password

Sign up and request more information.




COGNIZANT TO ACQUIRE MARKETRX, A LEADING PROVIDER OF LIFE SCIENCES MARKET ANALYTICS


COGNIZANT COMPLETES THE ACQUISITION OF MARKETRX





Corporate Headquarters
marketRx Inc.
1200 U.S. Route 22 East
Bridgewater, NJ 08807
Tel:908-541-0045
Fax:908-541-1595
 
marketRx announces partnership with Innovex

BRACKNELL, UK - October 3, 2006 - marketRx Inc., a leading provider of sales and marketing effectiveness solutions to the pharmaceutical Biotech and other life sciences industry, today announced a new working partnership with Innovex, a unit of Quintiles Transnational Corp. and a leading commercial solutions provider to pharmaceutical, biotech and medical device industries.

This new working partnership with marketRx will provide Innovex access to our high-end analytical tools and technologies. The partnership will unite marketRx's in-depth domain expertise, innovative analytical tools and technologies with Innovex's experience in building, managing and deploying sales teams in the UK.

"Working in partnership with Innovex will ensure that the pharmaceutical industry in the UK will have access to some of the most up to date analytical tools and technologies" said Alan Kalton, Vice President & General Manager, marketRx Europe "These innovative tools will ensure they are able to optimally target and deploy the most effective sales teams."

"This is an exciting opportunity for us. A working partnership with marketRx, an organization with a strong commitment to the research and development of new tools and technologies will ensure that Innovex continues to provide its customers with the best possible insights into their market place and in turn will ensure that we deliver truly effective targeted sales teams whose performance can be measured and tracked", explained Alison Clough, Managing Director of Innovex UK.

marketRx will maintain a dedicated Innovex resource, ensuring continuity and a high level of knowledge of both Innovex and its customers.


About Innovex

Innovex, a business unit of Quintiles Transnational, is the leading provider of contract sales forces, nurse adviser services and clinical resourcing solutions to the pharmaceutical industry in the United Kingdom. Established for more than 27 years, Innovex UK has created well over 70 sales teams in primary and secondary care, 60 nurse adviser programmes, and many clinical resourcing solutions to serve a wide range of therapeutic areas. www.innovex.co.uk


About Quintiles

Quintiles is the global leader in pharmaceutical services, improving healthcare worldwide by providing innovative, quality professional expertise, market intelligence and partnering solutions to meet the dynamic needs of the pharmaceutical, biotechnology and healthcare industries. Quintiles has 16,000 specialized employees and offices in 50 countries. For more information visit the company's Web site at www.quintiles.com


About marketRx

marketRx combines analytics, market research and technology to provide solutions that enable our customers at global pharmaceutical and biotechnology companies to improve the effectiveness of their sales and marketing initiatives.

Our business delivery model combines extensive industry knowledge with global online market research and analytical expertise to deliver actionable solutions in sales force strategy, tactical planning, targeting, brand management, quick-turnaround market research, segmentation, sales and marketing metrics, forecasting and brand tracking. Our technology enabled solutions also enable our customers to build internal capabilities by leveraging our R&D focus.

With all of the top-20 global pharmaceutical companies as customers and experience in more than 20 different countries, marketRx is the leading provider of integrated sales and marketing effectiveness solutions.


Contact:
Vikas Vats
marketRx, Inc.
marketing@marketrx.com
908-541-0045


Press releases




© 2000-2008 marketRx, Inc. All rights reserved.